Directors & Officers Disclosures
Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Hallenstein Glasson Holdings Limited (HLG)
Date this disclosure made:
6 November 2025
Date on which issuer listed or appointment made:
6 November 2025
Note: James McLauchlan was designated as a
Senior Manager of HLG on 6 November 2025.
His position in the HLG group did not change on
this date.
Director or senior manager giving disclosure
Full name:
James McLauchlan
Name of listed issuer:
Hallenstein Glasson Holdings Limited (HLG)
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Hallensteins Chief Executive Officer
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary Shares (NZX code: HLG)
Number held in class:
5,000
Nature of relevant interest: Beneficial owner (together with Lily Carlyon)
Current registered holder: JBWERE (NZ) NOMINEES LIMITED
Note: James McLauchlan acquired this relevant
interest on 30 September 2025 at which time he
was not designated as a Senior Manager of HLG.
Summary of specified derivatives relevant interest (if applicable)
Type of derivative:
Class of underlying financial products:
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price specified in the terms of the derivative(if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
6 November 2025
Name and title of authorised person:Cameron Alderton, Group Chief Financial Officer
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- HGH — Heartland Group Holdings Limited: Ongoing Disclosure Notice - J Harvey2025-09-18
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Heartland Group Holdings Limited Date this disclosure made: 18-Sep-25 Date of last…”
- HGH — Heartland Group Holdings Limited: Ongoing Disclosure Notice - S Beckett2025-10-10
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Heartland Group Holdings Limited Date this disclosure made: 10/10/2025 Date of las…”
- HGH — Heartland Group Holdings Limited: Ongoing Disclosure Notice - S Buggle2025-09-01
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Heartland Group Holdings Limited Date this disclosure made: 2/09/2025 Date of last…”